Background: Peri-implantitis is a significant complication in implant dentistry, characterized by the progressive loss of bone support around implants, often exacerbated by heavy bacterial colonization in dental plaque. Smoking, a known risk factor for periodontal disease, may adversely affect peri-implant tissue health and treatment outcomes. Objective: This systematic review aims to analyze the impact of smoking on the clinical treatment outcomes of peri-implantitis in adult patients, focusing on key clinical parameters and the effectiveness of various treatment modalities. Methods: A systematic search was conducted across several databases including PubMed, Scopus, Web of Science, and Google Scholar using keywords related to smoking and peri-implantitis treatment to identify relevant articles published in English language without any restriction for the time of publication until 30th September 2024. Studies were included on the eligibility criteria, emphasizing adult smokers with diagnosed peri-implantitis undergoing various treatments. Data extraction focused on clinical parameters outcomes including plaque index (PI), bleeding on probing (BOP), probing depth (PD), and bone levels. Results: Seven studies met the inclusion criteria, highlighting that smokers exhibited higher PI, BOP, and PD at baseline compared to non-smokers. Adjunctive therapies, particularly antimicrobial photodynamic therapy (aPDT), significantly improved clinical parameters in smokers. However, smokers demonstrated less favorable outcomes in gingival recession and bone levels post-treatment. Conclusion: Smoking negatively impacts the treatment outcomes of peri-implantitis, with smokers showing heightened inflammatory responses and less improvement in clinical parameters. Clinicians should consider smoking status when planning treatment protocols for peri-implantitis to optimize patient outcomes. Further research is warranted to develop targeted interventions for this vulnerable population.
Read full abstract